Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-21 Sale |
2021-06-23 5:28 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
1,777 | $61.61 | $109,481 | 3,555 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 4:10 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
1,118 | $55.89 | $62,485 | 0 (Direct) |
View |
| 2021-04-15 Sale |
2021-04-16 4:33 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
991 | $54 | $53,514 | 1,118 (Direct) |
View |
| 2020-09-02 Sale |
2020-09-04 4:24 pm |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
250 | $39.93 | $9,983 | 184 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Option Award |
2025-03-03 8:18 pm |
N/A 2035-02-27 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
90,500 | $0 | 90,500 (Direct) |
View |
| 2024-02-21 Option Award |
2024-02-23 5:01 pm |
N/A 2034-02-21 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
90,498 | $0 | 90,498 (Direct) |
View |
| 2023-04-18 Option Award |
2023-04-20 4:28 pm |
N/A 2033-04-18 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
6,254 | $0 | 6,254 (Direct) |
View |
| 2023-03-31 Option Award |
2023-04-04 8:22 pm |
N/A 2033-03-31 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
90,498 | $0 | 90,498 (Direct) |
View |
Ownership |
2022-10-19 8:05 pm |
N/A 2031-08-04 |
Prime Medicine Inc. | PRME | Alenson Carman See Remarks |
0 | $0 | 151,183 (Direct) |
View |
| 2021-06-21 Exercise |
2021-06-23 5:28 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
1,777 | $51.51 | 3,555 (Direct) |
View |
| 2021-06-21 Exercise |
2021-06-23 5:28 pm |
N/A 2030-02-14 |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
1,777 | $0 | 3,555 (Direct) |
View |
| 2021-02-22 Tax Withholding |
2021-02-24 4:12 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
199 | $0 | 2,486 (Direct) |
View |
| 2021-02-22 Exercise |
2021-02-24 4:12 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
692 | $0 | 2,486 (Direct) |
View |
| 2021-02-16 Tax Withholding |
2021-02-17 4:13 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
561 | $0 | 3,079 (Direct) |
View |
| 2021-02-14 Exercise |
2021-02-17 4:13 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
1,679 | $0 | 3,079 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 4:22 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
8,883 | $0 | 8,883 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:38 pm |
N/A N/A |
AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer |
5,000 | $0 | 5,000 (Direct) |
View |